Skip to main content
Donate

Researchers

FAST E-Journal

FAST Dart E-Journal Logo

Welcome to FAST DART, a free online archive and e-journal dedicated to advancing Angelman syndrome research. Here, researchers can share unpublished data, preprints, negative or null results, biotechniques in development, and literature reviews to foster collaboration and innovation in the AS community. By openly sharing results and insights, even those not traditionally published, we aim to prevent duplication, refine approaches, and accelerate the path toward new therapies. We invite you to contribute your work and help build a transparent and dynamic resource for all working to better understand and treat Angelman syndrome.

About the e-Journal

Submit Your Data

About this Data

Articles by Type

Reviews

  • Title

Biotechniques

  • Title

Original Papers

  • Title

FAST Angelman Syndrome News

Ionis Receives Breakthrough Therapy Designation for ION582 in Angelman Syndrome

FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome

FAST Global: Cure Angelman Now Fundraising Efforts

CAN Spotlight: Payslie’s Pals Cornhole Tournament Brings Community Together for FAST Research

CAN Spotlight: Honoring “Hendu” with Hope and Research: The Always Having Fun Foundation’s Golf Classic

Turning Possibility Into Progress: The Rush F.A.S.T. Center for Translational Research Opens in Chicago

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelma...

Inside INSYNC-AS 2025: Progress, Partnership, and Possibilities for Angelman Syndrome

The LaMuras organized Rally for a Cure, a Tennis-Themed Event that Brought Together Their Community

Charlie's Angels Chari-Tee Golf Tournament: A Day of Hope, Community, and Action

Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine

Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career...

First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome

Leading Neurology and Rare Disease Expert Dr. Nick France Joins FAST Board

FAST Announces Funding For First Innovative Seed Grant

CAN Spotlight: Kettlebells for Kayleigh Fundraiser in Germany

CAN SPOTLIGHT: Skating Angels Charity Ice Hockey Tournament

More Than a Seat at the Table: FAST’s Role in Shaping the Future of Angelman Syndrome at ASGCT 2025

MavriX Bio Announces FDA Clearance of IND Application to Initiate First-in-Human Study of Gene Therapy ...

Ionis Receives Breakthrough Therapy Designation for ION582 in Angelman Syndrome

FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome

FAST Global: Cure Angelman Now Fundraising Efforts

CAN Spotlight: Payslie’s Pals Cornhole Tournament Brings Community Together for FAST Research

CAN Spotlight: Honoring “Hendu” with Hope and Research: The Always Having Fun Foundation’s Golf Classic

Turning Possibility Into Progress: The Rush F.A.S.T. Center for Translational Research Opens in Chicago

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelma...

Inside INSYNC-AS 2025: Progress, Partnership, and Possibilities for Angelman Syndrome

The LaMuras organized Rally for a Cure, a Tennis-Themed Event that Brought Together Their Community

Charlie's Angels Chari-Tee Golf Tournament: A Day of Hope, Community, and Action

Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine

Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career...

First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome

Leading Neurology and Rare Disease Expert Dr. Nick France Joins FAST Board

FAST Announces Funding For First Innovative Seed Grant

CAN Spotlight: Kettlebells for Kayleigh Fundraiser in Germany

CAN SPOTLIGHT: Skating Angels Charity Ice Hockey Tournament

More Than a Seat at the Table: FAST’s Role in Shaping the Future of Angelman Syndrome at ASGCT 2025

MavriX Bio Announces FDA Clearance of IND Application to Initiate First-in-Human Study of Gene Therapy ...

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.